Adrenomyeloneuropathy as a cause of primary adrenal insufficiency and spastic paraparesis

CMAJ. Canadian Medical Association Journal

Volumn 171, Issue 9, 2004, Pages 1073-1077

  Spurek, Monika ^a   Taylor Gjevre, Regina ^a   Van Uum, Stan ^a   Khandwala, Hasnain M ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; LORENZO OIL; MINERALOCORTICOID; VERY LONG CHAIN FATTY ACID;

ABDOMINAL PAIN; ADRENAL GLAND; ADRENAL INSUFFICIENCY; ADRENOLEUKODYSTROPHY; ADULT; ANOREXIA; BONE MARROW TRANSPLANTATION; BRAIN VENTRICLE DILATATION; CASE REPORT; CLINICAL FEATURE; HUMAN; MALE; MUSCLE WEAKNESS; PERIPHERAL NERVOUS SYSTEM; REVIEW; SPASTIC PARAPLEGIA; TESTIS; THROMBOCYTOPENIA;

EID: 7944237679     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: 10.1503/cmaj.1032006     Document Type: Review

References (34)

1. Van Geel BM, Assies J, Wanders RJA, Barth PG. X-linked adrenoleukodystrophy: clinical presentation, diagnosis and therapy. J Neurol Neurosurg Psychiatry 1997 Jul;63(1):4-14.
2. Bezman L, Moser AB, Raymond GV, Rinaldo P, Watkins PA, Smith KD, et al. Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann Neurol 2001;49:S12-7.
3. Wanders RJA, Tager JA. Peroxisomal Fatty acid B-oxidation in adrenoleukodystrophy. Dev Neurosci 1991;13:262-6.
4. Lazo D, Contreras M, Hashmi M, Stanley W, Irazu C, Singh T. Peroxisomal Iignoceroyl CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy. Proc Natl Acad Sci USA 1988;85:7647-51.
5. Johnson AB, Schaumburg HH, Powers JM. Histochemical characteristics of the striated inclusions of adrenoleukodystrophy. J Histochem Cytochem 1976; 24:725-30.
6. Siemerling E, Creudzfeldt HG. Brozzkrankheit und sclerosierende encephalomyelitis. Arch fr psychiatrie 1923;68:217-44.
7. Griffen JW, Goren E, Schaumburg H, Engel WK, Loriaux L. Adrenomyeloneuropathy: a possible variant of adrenoleukodystrophy. Neurol 1977;27: 1107-13.
8. Budka H, Sluga E, Heiss WD. Spastic paraplegia associated with Addison's disease: a variant of adrenoleukodystrophy. J Neurol 1976;213:237-50.
9. Migeon BR, Moser HW, Moser AB, Axelman J, Sillenece D, Norum RA. Adrenoleukodystrophy: evidence for X linkage, inactivation, and selection favoring the mutant allele in the heterozygous cells. Proc Natl Acad Sci USA 1982;78:5066-70.
10. Ligtenberg MJ, Kemp S, Sarde CO, van Geel BM, Kleijer WJ, Barth PG, et al. Spectrum of mutations in the gene encoding the adrenoleukodystrophy protein. Am J Hum Genet 1995;56:44-50.
11. Moser HW, Moser AJB, Naidu S, Bergin A. Clinical aspects of adrenoleukodystrophy and adrenomyeloneuropathy. Dev Neurosci 1991;13:254-61.
12. Van Geel BM, Assies J, Weverling GJ, Barth PG. Predominance of the adrenomyeloneuropathy phenotype of X-linked adrenoleukodystrophy in the Netherlands. Neurol 1994;44:2243-6.
13. Ohno T, Tsuchida H, Fukuhara N, Yuasa T, Harayama H, Tsjui S, et al. Adrenoleukodystrophy: a clinical variant presenting as olivopontocerebellar atrophy. J Neurol 1984;231:167-9.
14. Powers JM, Schaumburg HH. The testis in adrenoleukodystrophy. Am J Pathol 1981;102:90-8.
15. Moser AB, Kreiter N, Bezman L, Lu S, Raymond GV, Naidu S, et al. Plasma very long chain fatty acids in 3000 peroxisome disease patients and 29 000 controls. Ann Neurol 1999;45:100-10.
16. Dooley JM, Wright BA. Adrenoleukodystrophy mimicking multiple sclerosis. J Can Sci Neurol 1985;12:73-4.
17. Moser HW, Bergin A, Naidu S, Ladenson PW. Adrenoleukodystrophy. Endocrinol Metab Clin North Am 1991;20:297-318.
18. Aubourg P, Adamsbaum C, Lavallard-Rousseau MC, Lamaitre A, Boureau F, Mayer M, et al. Brain MRI and electrophysiologic abnormalities in preclinical and clinical adrenomyeloneuropathy. Neurol 1992;42:85-91.
19. Boue J, Oberle I, Mandel JL, Moser HW, Larsen JW, Dumez Y, et al. First trimester prenatal diagnosis of adrenoleukodystrophy by determination of very long chain fatty acid levels and by linkage analysis to a DNA probe. J Hum Genet 1985;69:272-4.
20. Sadeghi-Nejad A, Senior B. Adrenomyeloneuropathy presenting as Addison's disease in childhood. New Engl J Med 1990;322:13-6.
21. Lauretti S, Casucci G, Santeusanio F, Angeletti G, Aubourg P, Brunetti P. X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison's disease in young adult male patients. J Clin Endocrinol Metab 1996;81:470-4.
22. Holmberg BH, Hagg E, Duchek M, Hagenfeldt L. Screening of patients with heredity spastic paraparesis and Addison's disease for adrenoleukodystrophy/ adrenomyeloneuropathy. Acta Neurol Scand 1992;85:147-9.
23. Moser HW, Aoubourg P, Cornblath D. Therapy of X-linked adrenoleukodystrophy. In: Desnick RJ, ed. Treatment of genetic diseases. New York: Churchill Livingstone; 1991. p. 111-29.
24. Rizzo WB, Phillips MW, Damman AL. Adrenoleukodystrophy:dietary oleic acid lowers hexacosanoate levels. Ann Neurol 1987;21:232-9.
25. Brown FR, Van Duyn MA, Moser AB. Adrenoleukodystrophy: effects of dietary restriction of very long chain fatty acids and of administration of carnitine and clofibrate on clinical status and plasma fatty acids. Johns Hopkins Med J 1982;151:164-72.
26. Aubourg PK, Adamsbaum C, Lavallard-Rousseau MC, Rocchiccioli F, Carrier N, Jambaque I, et al. A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy. New Engl J Med 1993;329: 745-52.
27. Uziel G, Bertini E, Bardelli P, Rimoldi M, Gambetri M. Experience on therapy of adrenoleukodystrophy and adrenomyeloneuropathy. Dev Neurosci 1991;13;274-9.
28. Weinberg K, Moser A, Watkins P, Lenarsky C, Winter S, Moser H, et al. Bone marrow transplantation for adrenoleukodystrophy [abstract]. Pediatr Res 1988;23:334A.
29. Aubourg P, Blance S, Jahnbaque I, Kalifa G. Reversible of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. New Engl J Med 1990;322:1860-6.
30. Stumpf DA, Hayward A, Haas R, Schuamburg HH. Adrenoleukodystrophy. Failure of immunosuppression to prevent neurologic progression. Arch Neurol 1991;38:48-9.
31. Naidu S, Bresnan MJ, Griffen D, O'toole S, Moser HW. Intensive immunosuppression fails to alter neurological progression in childhood adrenoleukodystrophy. Arch Neurol 1988;45:846-8.
32. Miike T, Taku K, Tamura T, Ohta J, Ozaki MY, Sakai T, et al. Clinical improvement of adrenoleukodystrophy following intravenous gammaglobulin therapy. Brain Dev 1989;11:134-7.
33. Noel P, Nelson S, Bokulic R, Bagby G, Lippton H, Lipscomb G, et al. Pentoxyfilline inhibits lipopolysaccharide-induced serum tumor necrosis factor and mortality. Life Sci 1990;47:1023-9.
34. Singh I, Khan M, Key L, Pai S. Lovastatin for X linked adrenoleukodystrophy. N Engl J Med 1998;309:702-3.